U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07375992) titled 'Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)' on Jan. 21.
Brief Summary: The Brain Cancer Program, in partnership with the Center for Music and Medicine at Johns Hopkins, will study whether music therapy is feasible in newly diagnosed GBM patients undergoing standard care.
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Feasibility Studies
Intervention:
OTHER: Music intervention
Each GBM study participant in Arm A will receive two 30-minute live synchronous virtual music therapy sessions per week for a period of 8 weeks to be curated by a board-certified music ther...